171 related articles for article (PubMed ID: 38233507)
41. Single factors alone can induce mesenchymal-like morphology, but not promote full EMT in breast cancer cell lines with different hormone statuses.
Tveitarås MK; Reigstad I; Leiss L; Reed RK; Stuhr L
Exp Cell Res; 2017 Oct; 359(1):257-265. PubMed ID: 28734865
[TBL] [Abstract][Full Text] [Related]
42. Increased entropy of signal transduction in the cancer metastasis phenotype.
Teschendorff AE; Severini S
BMC Syst Biol; 2010 Jul; 4():104. PubMed ID: 20673354
[TBL] [Abstract][Full Text] [Related]
43. A microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β
Crippa M; Bersini S; Gilardi M; Arrigoni C; Gamba S; Falanga A; Candrian C; Dubini G; Vanoni M; Moretti M
Lab Chip; 2021 Mar; 21(6):1061-1072. PubMed ID: 33522559
[TBL] [Abstract][Full Text] [Related]
44. Glycosaminoglycans as Tools to Decipher the Platelet Tumor Cell Interaction: A Focus on P-Selectin.
Schwarz S; Gockel LM; Naggi A; Barash U; Gobec M; Bendas G; Schlesinger M
Molecules; 2020 Feb; 25(5):. PubMed ID: 32110917
[TBL] [Abstract][Full Text] [Related]
45. Benign mammary epithelial cells enhance the transformed phenotype of human breast cancer cells.
Poczobutt JM; Tentler J; Lu X; Schedin PJ; Gutierrez-Hartmann A
BMC Cancer; 2010 Jul; 10():373. PubMed ID: 20637104
[TBL] [Abstract][Full Text] [Related]
46. The secretome in cancer progression.
Paltridge JL; Belle L; Khew-Goodall Y
Biochim Biophys Acta; 2013 Nov; 1834(11):2233-41. PubMed ID: 23542208
[TBL] [Abstract][Full Text] [Related]
47. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.
Nouhi Z; Chughtai N; Hartley S; Cocolakis E; Lebrun JJ; Ali S
Cancer Res; 2006 Feb; 66(3):1824-32. PubMed ID: 16452244
[TBL] [Abstract][Full Text] [Related]
48. IL-36 signalling enhances a pro-tumorigenic phenotype in colon cancer cells with cancer cell growth restricted by administration of the IL-36R antagonist.
Baker K; O'Donnell C; Bendix M; Keogh S; Byrne J; O'Riordain M; Neary P; Houston A; Brint E
Oncogene; 2022 May; 41(19):2672-2684. PubMed ID: 35365751
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of vitamin-producing and immunomodulatory lactic acid bacteria as a potential co-adjuvant for cancer therapy in a mouse model.
Levit R; Savoy de Giori G; de Moreno de LeBlanc A; LeBlanc JG
J Appl Microbiol; 2021 Jun; 130(6):2063-2074. PubMed ID: 33128836
[TBL] [Abstract][Full Text] [Related]
50. Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis.
Eyre R; Alférez DG; Spence K; Kamal M; Shaw FL; Simões BM; Santiago-Gómez A; Sarmiento-Castro A; Bramley M; Absar M; Saad Z; Chatterjee S; Kirwan C; Gandhi A; Armstrong AC; Wardley AM; O'Brien CS; Farnie G; Howell SJ; Clarke RB
J Mammary Gland Biol Neoplasia; 2016 Dec; 21(3-4):99-109. PubMed ID: 27680982
[TBL] [Abstract][Full Text] [Related]
51. Integration of molecular profiling and chemical imaging to elucidate fibroblast-microenvironment impact on cancer cell phenotype and endocrine resistance in breast cancer.
Holton SE; Bergamaschi A; Katzenellenbogen BS; Bhargava R
PLoS One; 2014; 9(5):e96878. PubMed ID: 24816718
[TBL] [Abstract][Full Text] [Related]
52. Exosomes from the tumour-adipocyte interplay stimulate beige/brown differentiation and reprogram metabolism in stromal adipocytes to promote tumour progression.
Wu Q; Li J; Li Z; Sun S; Zhu S; Wang L; Wu J; Yuan J; Zhang Y; Sun S; Wang C
J Exp Clin Cancer Res; 2019 May; 38(1):223. PubMed ID: 31138258
[TBL] [Abstract][Full Text] [Related]
53. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
Bakiri L; Macho-Maschler S; Custic I; Niemiec J; Guío-Carrión A; Hasenfuss SC; Eger A; Müller M; Beug H; Wagner EF
Cell Death Differ; 2015 Feb; 22(2):336-50. PubMed ID: 25301070
[TBL] [Abstract][Full Text] [Related]
54. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
55. Effects of the scaffold proteins liprin-α1, β1 and β2 on invasion by breast cancer cells.
Chiaretti S; Astro V; Chiricozzi E; de Curtis I
Biol Cell; 2016 Mar; 108(3):65-75. PubMed ID: 26663347
[TBL] [Abstract][Full Text] [Related]
56. Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact.
Reid PE; Brown NJ; Holen I
Mol Cancer; 2009 Jul; 8():49. PubMed ID: 19604388
[TBL] [Abstract][Full Text] [Related]
57. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis.
Ören B; Urosevic J; Mertens C; Mora J; Guiu M; Gomis RR; Weigert A; Schmid T; Grein S; Brüne B; Jung M
J Pathol; 2016 Jul; 239(3):274-85. PubMed ID: 27038000
[TBL] [Abstract][Full Text] [Related]
58. Mesenchymal stromal cell activation by breast cancer secretomes in bioengineered 3D microenvironments.
Blache U; Horton ER; Xia T; Schoof EM; Blicher LH; Schönenberger A; Snedeker JG; Martin I; Erler JT; Ehrbar M
Life Sci Alliance; 2019 Jun; 2(3):. PubMed ID: 31160380
[TBL] [Abstract][Full Text] [Related]
59. Effect of homotypic and heterotypic interaction in 3D on the E-selectin mediated adhesive properties of breast cancer cell lines.
Chandrasekaran S; Geng Y; DeLouise LA; King MR
Biomaterials; 2012 Dec; 33(35):9037-48. PubMed ID: 22992472
[TBL] [Abstract][Full Text] [Related]
60. Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells.
Borley AC; Hiscox S; Gee J; Smith C; Shaw V; Barrett-Lee P; Nicholson RI
Breast Cancer Res; 2008; 10(6):R103. PubMed ID: 19055788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
